{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:47:56Z","timestamp":1782870476968,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Medical Science Research Project of Hebei Province","award":["20220810"],"award-info":[{"award-number":["20220810"]}]},{"name":"the Government-funded Clinical Medicine Excellent Talents Training Program of Hebei Province","award":["ZF2026032"],"award-info":[{"award-number":["ZF2026032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify prognostic factors and develop a predictive tool for patients with hilar cholangiocarcinoma (HCCA) undergoing R1 or R2 resection, thereby informing patient selection and individualized treatment decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted of HCCA patients who underwent R1 or R2 resection at a single center. Independent prognostic factors were identified using Cox regression analysis, and a predictive nomogram was constructed using R software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Multivariate analysis identified four independent prognostic factors: surgical margin status (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002), tumor differentiation grade (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.030), vascular invasion (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and adjuvant therapy (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.023). The nomogram based on these factors demonstrated favorable discriminatory ability, with a C-index of 0.780. Time-dependent receiver operating characteristic (ROC) analysis yielded areas under the curve (AUC) of 0.904 (95% confidence interval [CI]: 0.831\u20130.966) and 0.822 (95% CI: 0.736\u20130.897) for predicting 1-year and 2-year survival, respectively. Patients stratified into high-risk and low-risk groups by the nomogram showed significantly different survival outcomes (1-year survival: 44% vs. 92.5%; 2-year survival: 20% vs. 52.8%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The developed nomogram effectively predicts prognosis following R1 or R2 resection for HCCA, demonstrating good discrimination and short-term predictive accuracy. It serves as a useful tool for postoperative risk stratification and personalized management planning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12893-026-03776-5","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:02:22Z","timestamp":1778047342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of prognostic factors for R1\/R2 resection in patients with hilar cholangiocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Zepu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuncheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"8","key":"3776_CR1","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1245\/s10434-021-09871-6","volume":"28","author":"KC Soares","year":"2021","unstructured":"Soares KC, Jarnagin WR. The Landmark Series: Hilar Cholangiocarcinoma. Ann Surg Oncol. 2021;28(8):4158\u201370.","journal-title":"Ann Surg Oncol"},{"key":"3776_CR2","volume-title":"WHO classification of tumours: digestive system tumours","author":"WHO Classification of Tumours Editorial Board","year":"2019","unstructured":"WHO Classification of Tumours Editorial Board. WHO classification of tumours: digestive system tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2019.","edition":"5"},{"issue":"2","key":"3776_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/SLA.0000000000004322","volume":"275","author":"T Mizuno","year":"2022","unstructured":"Mizuno T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Combined Vascular Resection for Locally Advanced Perihilar Cholangiocarcinoma. Ann Surg. 2022;275(2):382\u201390.","journal-title":"Ann Surg"},{"key":"3776_CR4","first-page":"17","volume":"10","author":"M Ohtsuka","year":"2024","unstructured":"Ohtsuka M, Takayashiki T, Takano S, Hidaka H, Suzuki D, Eguchi S. Lymphatic spread from left-sided intrahepatic cholangiocarcinoma: reconsiderations based on the lymphatic drainage from the liver. Hepatoma Res. 2024;10:17.","journal-title":"Hepatoma Res"},{"issue":"10272","key":"3776_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397(10272):428\u201344.","journal-title":"Lancet"},{"issue":"4","key":"3776_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BSJ, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507\u201319.","journal-title":"Ann Surg"},{"issue":"3","key":"3776_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5306\/wjco.v15.i3.381","volume":"15","author":"M Makki","year":"2024","unstructured":"Makki M, Bentaleb M, Abdulrahman M, Al-Thani H, El-Menyar A. Current interventional options for palliative care for patients with advanced-stage cholangiocarcinoma. World J Clin Oncol. 2024;15(3):381\u201390.","journal-title":"World J Clin Oncol"},{"issue":"9","key":"3776_CR8","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1007\/s11605-012-1960-0","volume":"16","author":"MS Cho","year":"2012","unstructured":"Cho MS, Kim SH, Park SW, Lim JH, Choi GH, Park JS, et al. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience. J Gastrointest Surg. 2012;16(9):1672\u20139.","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"3776_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12262-016-1581-z","volume":"80","author":"Z Yu","year":"2018","unstructured":"Yu Z, Zhu J, Jiang H, Li Z, Chen L. Surgical Resection and Prognostic Analysis of 142 Cases of Hilar Cholangiocarcinoma. Indian J Surg. 2018;80(4):309\u201317.","journal-title":"Indian J Surg"},{"issue":"5","key":"3776_CR10","doi-asserted-by":"publisher","first-page":"S1275","DOI":"10.1016\/S0016-5085(17)34251-8","volume":"152","author":"X Li","year":"2017","unstructured":"Li X. Surgical Outcomes and Prognostic Factors in Patients with Hilar Cholangiocarcinoma: Radical Resection and Preoperative Bilirubin Level were Independent Prognostic Factors of Tumor Recurrence and Overall Survival Rate. Gastroenterology. 2017;152(5):S1275.","journal-title":"Gastroenterology"},{"issue":"4 suppl","key":"3776_CR11","first-page":"486","volume":"36","author":"G Lee","year":"2025","unstructured":"Lee G, Lee J, Kim S, Choi Y, Park I. Retrospective study of postoperative chemoradiation of cholangiocarcinoma in South Korea: Efficacy, side effect, and prognostic factors. J Clin Oncol. 2025;36(4 suppl):486.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3776_CR12","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.47391\/JPMA.21670","volume":"75","author":"AA Khursheed","year":"2025","unstructured":"Khursheed AA, Khan MR, Saeed J. Early postoperative outcomes in patients with resectable extrahepatic biliary tumours: A single center retrospective cross sectional study. J Pak Med Assoc. 2025;75(10):1569\u201374.","journal-title":"J Pak Med Assoc"},{"issue":"16","key":"3776_CR13","first-page":"2886","volume":"27","author":"PR Cheng","year":"2019","unstructured":"Cheng PR, Su Y. Analysis of clinicopathological features and prognostic factors in patients with resectable hilar cholangiocarcinoma. Mod Oncol. 2019;27(16):2886\u201390.","journal-title":"Mod Oncol"},{"issue":"10","key":"3776_CR14","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s00268-016-3551-9","volume":"40","author":"MJ Kang","year":"2016","unstructured":"Kang MJ, Jang JY, Chang J, Shin YC, Lee D, Kim SW. Actual Long-Term Survival Outcome of 403 Consecutive Patients with Hilar Cholangiocarcinoma. World J Surg. 2016;40(10):2451\u20139.","journal-title":"World J Surg"},{"issue":"2","key":"3776_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4174\/astr.2025.109.2.71","volume":"109","author":"H Jeong","year":"2025","unstructured":"Jeong H, Kim HJ, Lim SY, Park YI, Lee CH, Park JS. Five-year survival of patients with hilar cholangiocarcinoma: a single-center retrospective study. Ann Surg Treat Res. 2025;109(2):71\u201380.","journal-title":"Ann Surg Treat Res"},{"issue":"3","key":"3776_CR16","first-page":"299","volume":"108","author":"N Vladov","year":"2013","unstructured":"Vladov N, Lukanova T, Takorov I, Odisseeva Z, Ivanov Z, Sergeev S, et al. Single centre experience with surgical treatment of hilar cholangiocarcinoma. Chirurgia (Bucur). 2013;108(3):299\u2013303.","journal-title":"Chirurgia (Bucur)"},{"issue":"1","key":"3776_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00423-023-03023-y","volume":"408","author":"N Nevermann","year":"2023","unstructured":"Nevermann N, Bode J, Vischer M, Staib L, Sch\u00f6ning W, Keck T. A surgical strategy for intrahepatic cholangiocarcinoma - the hilar first concept. Langenbecks Arch Surg. 2023;408(1):296.","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"3776_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5152\/tjg.2018.17752","volume":"30","author":"V Oter","year":"2019","unstructured":"Oter V, Ozer I, Dalgic T, Ulas M, Ozgor D, Aydin C, et al. Results of positive proximal margin after resection for hilar cholangiocarcinoma: An analysis of 42 cases. Turk J Gastroenterol. 2019;30(1):88\u201394.","journal-title":"Turk J Gastroenterol"},{"issue":"2","key":"3776_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.sla.0000217639.10331.47","volume":"244","author":"H Witzigmann","year":"2006","unstructured":"Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1\/r2 resection. Ann Surg. 2006;244(2):230\u20139.","journal-title":"Ann Surg"},{"issue":"5","key":"3776_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/000313481107700525","volume":"77","author":"L Zheng-Rong","year":"2011","unstructured":"Zheng-Rong L, Hai-Bo Y, Xin C, Dong-Sheng Y, Yi L. Resection and drainage of hilar cholangiocarcinoma: an 11-year experience of a single center in mainland China. Am Surg. 2011;77(5):627\u201333.","journal-title":"Am Surg"},{"issue":"11","key":"3776_CR21","first-page":"7890","volume":"7","author":"WK Cai","year":"2014","unstructured":"Cai WK, Lin JJ, He GH, Wang H, Wu DH. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma. Int J Clin Exp Pathol. 2014;7(11):7890\u20138.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"3776_CR22","first-page":"1122","volume":"8","author":"Y Wang","year":"2015","unstructured":"Wang Y, Yang H, Shen C, Luo R, Li J, Bai L. Surgical procedure and long-term survival of hilar cholangiocarcinoma. Int J Clin Exp Med. 2015;8(1):1122\u20138.","journal-title":"Int J Clin Exp Med"},{"key":"3776_CR23","volume-title":"WHO classification of tumours of the digestive system","author":"FT Bosman","year":"2010","unstructured":"Bosman FT. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010.","edition":"4"},{"issue":"12","key":"3776_CR24","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.humpath.2012.04.003","volume":"43","author":"J Albores-Saavedra","year":"2012","unstructured":"Albores-Saavedra J, Chable-Montero F, Mendez-Sanchez N, Angeles-Angeles A. Adenocarcinoma with pyloric gland phenotype of the extrahepatic bile ducts: a previously unrecognized and distinctive morphologic variant of extrahepatic bile duct carcinoma. Hum Pathol. 2012;43(12):2292\u20138.","journal-title":"Hum Pathol"},{"issue":"4","key":"3776_CR25","first-page":"503","volume":"114","author":"MN Mavros","year":"2016","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Impact of tumor differentiation on prognosis and treatment strategy for intrahepatic cholangiocarcinoma. J Surg Oncol. 2016;114(4):503\u20139.","journal-title":"J Surg Oncol"},{"issue":"8","key":"3776_CR26","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1007\/s00595-021-02249-x","volume":"51","author":"XW Ye","year":"2021","unstructured":"Ye XW, Hu HJ, Xiong XZ, Li FY. The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma. Surg Today. 2021;51(8):1352\u201360.","journal-title":"Surg Today"},{"key":"3776_CR27","doi-asserted-by":"publisher","first-page":"1071439","DOI":"10.3389\/fonc.2022.1071439","volume":"12","author":"G Heng","year":"2022","unstructured":"Heng G, Huang B, Shen Y, Wang J, Yang L, Chen B, et al. Vascular invasion and lymph node metastasis mediate the effect of CA242 on prognosis in hilar cholangiocarcinoma patients after radical resection. Front Oncol. 2022;12:1071439.","journal-title":"Front Oncol"},{"key":"3776_CR28","doi-asserted-by":"crossref","unstructured":"Sahai V, Griffith KA, Zhen DB, Ejadi S, Harris WP, Munster PN et al. Phase 1b\/2 results of a multicenter, randomized phase 1b\/2 study of gemcitabine and cisplatin +\/- devimistat as first-line therapy for patients with advanced biliary tract cancer (BilT-04). J Clin Oncol. 2024;42(16_suppl):4116.","DOI":"10.1200\/JCO.2024.42.16_suppl.4116"},{"issue":"1","key":"3776_CR29","doi-asserted-by":"publisher","first-page":"e1483","DOI":"10.1002\/cti2.1483","volume":"13","author":"M Zhou","year":"2024","unstructured":"Zhou M, Jin Y, Zhu S, Zhang H, Wang L, Zhao M, et al. A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer. Clin Transl Immunol. 2024;13(1):e1483.","journal-title":"Clin Transl Immunol"},{"issue":"1","key":"3776_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128\u201338.","journal-title":"Epidemiology"},{"issue":"4","key":"3776_CR31","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u201380.","journal-title":"Lancet Oncol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-026-03776-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03776-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03776-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:10:38Z","timestamp":1782868238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12893-026-03776-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3776"],"URL":"https:\/\/doi.org\/10.1186\/s12893-026-03776-5","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The protocol was reviewed and approved by the Institutional Review Board (IRB)\/Ethics Committee of Hebei General Hospital (Approval No. 2021\u2009\u2212\u2009157). The requirement for written informed consent was formally waived by the IRB\/Ethics Committee. This waiver is in compliance with the national \u201cEthical Review Measures for Life Science and Medical Research Involving Human Subjects\u201d due to the retrospective nature of the research and the use of fully anonymized patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}